ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0918

Network Analysis of Genome Sequences Identifies Important Pathways in the Pathogenesis of Childhood-onset Systemic Lupus Erythematosus

Katie Heitzman1, Sneha Dass1, Linda Hiraki2, Earl Silverman3, Christiaan Scott4, Ana Barrera-Vargas5, Zuoming Deng6, Mariana Kaplan7, Luis Franco8 and Laura Lewandowski9, 1Lupus Genetics and Global Health Disparities Unit, Systemic Autoimmunity Branch, NIAMS, Bethesda, MD, 2The Hospital for Sick Children, Toronto, ON, Canada, 3Silverman, Toronto, ON, Canada, 4Paediatric Rheumatology, Red Cross War Memorial Children’s Hospital and University of Cape Town, Cape Town, South Africa, 5Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 6National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 7Lupus Clinical Trials Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH); Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, 8Functional Immunogenomics Section, Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, MD, 9Lupus Genetics and Global Health Disparities Unit, Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, MD

Meeting: ACR Convergence 2023

Keywords: Bioinformatics, genetics, genomics, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0899–0933) SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disorder. The pathogenesis of SLE is not fully understood, but high twin/sibling concordance rates suggest a genetic component triggered by environmental events. Childhood-onset SLE (cSLE) patients have an extreme phenotype, therefore is an ideal population to study genetic contributors to SLE. Historically, studies have focused on unrelated individulas who share variants in individual genes. However, this approach doesn’t consider that rare variants in SLE could cluster in genes participating in related biological processes. We performed genome sequencing in a diverse cohort of cSLE patients and parental controls, and describe a network-of-pathways approach to identify biological pathways enriched in genes with rare variants that may contribute to cSLE pathogenesis.

Methods: SLE patients met at least 4 of 11 revised American College of Rheumatology classification criteria, with disease onset 18 years. Whole blood samples were collected from 83 patients with cSLE and 109 unaffected parents and whole genome sequencing was performed. The genome sequences were filtered to select for rare (minor allele frequency< 0.01), nonsynonymous variants in coding exons. Selected variants had to be present only in cSLE patients or in both patients and parents, but at a significantly higher level in patients (Fisher’s exact test (p0.05)).This resulted in 501 unique variants, which corresponded to 232 genes.Using the 232 genes, we performed pathway enrichment analysis based on Gene Ontology biological processes with Metascape. We generate a network of enriched pathways, weighted by enrichment values and overlap coefficients with Cytoscape. Pathway clusters in the network were manually reviewed and classified. We analyzed clinical phenotypes and CADD-Phred for each pathway cluster.

Results: Rare genetic variants in cSLE patients are enriched in biological pathways such as RNA processing and apoptosis (Figure 1). Some pathways(i.e. nucleic acid regulation) are well-established causes of monogenic SLE, while others are novel. The median CADD-Phred score for each of the 18 networks ranges from 11.5-23.6.The mitochondrial functions cluster had higher rates of lupus nephritis, and the cell adhesion cluster had higher rates of CNS SLE compared to other clusters (Figure 2).

Conclusion: Network analysis is a useful approach to identify biological pathways and specific genes that could contribute to cSLE risk. Ongoing detailed analysis of the specific variants identified in each pathway will allow us to prioritize key genes and pathways for further study. In total, this analysis may contribute to advancing the understanding of cSLE beyond a broad clinical phenotype and towards a more precise molecular diagnosis.

Supporting image 1

Table 1. Demographic data of the cSLE cohort

Supporting image 2

Figure 1. Biologic pathways enriched in rare coding variants in cSLE patients.

Supporting image 3

Figure 2. Key phenotypes for variants enriched in cSLE grouped by functional biologic clusters


Disclosures: K. Heitzman: None; S. Dass: None; L. Hiraki: None; E. Silverman: None; C. Scott: None; A. Barrera-Vargas: None; Z. Deng: None; M. Kaplan: AstraZeneca, 5, Bristol Myers Squibb, 5, Cytrill, 2, Neutrolis, 2; L. Franco: None; L. Lewandowski: None.

To cite this abstract in AMA style:

Heitzman K, Dass S, Hiraki L, Silverman E, Scott C, Barrera-Vargas A, Deng Z, Kaplan M, Franco L, Lewandowski L. Network Analysis of Genome Sequences Identifies Important Pathways in the Pathogenesis of Childhood-onset Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/network-analysis-of-genome-sequences-identifies-important-pathways-in-the-pathogenesis-of-childhood-onset-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/network-analysis-of-genome-sequences-identifies-important-pathways-in-the-pathogenesis-of-childhood-onset-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology